Herein, we constructed a DNA-based nanodrug loaded with Cu2+ and glucose oxidase (GOx) for synergistic cancer therapy, namely, glucose oxidase-copper-DNA hybrid nanoflower (GCD). The gene discussed is HAO1; the disease is cancer.